Glaukos Breaks Ground on New Huntsville R&D Facility
September 26, 2025
Planned Investment of $80+ Million in 200,000 Square-Foot State-of-the-Art Facility Supports Glaukos’ Long-Term Growth Plans and Reinforces Commitment to U.S. Manufacturing Glaukos Corporation, an ophthalmic
